InVitria Launches Zap-Hybridoma For Hybridoma Cell Culture
Zap-Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product. Zap-Hybridoma was developed by InVitria’s cell culture development team. Steve Pettit, director
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.